Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUSTAIN study).
Saved in:
| Title: | Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUSTAIN study). |
|---|---|
| Authors: | Foley, Peter1,2 (AUTHOR) pfoley@skinhealthinstitute.org.au, Manuelpillai, Nick1 (AUTHOR), Dolianitis, Con2,3 (AUTHOR), Cains, Geoffrey D.4 (AUTHOR), Mate, Eric5 (AUTHOR), Tronnberg, Rebecca5 (AUTHOR), Baker, Christopher1,2 (AUTHOR) |
| Source: | Australasian Journal of Dermatology. Aug2022, Vol. 63 Issue 3, p303-311. 9p. 1 Diagram, 2 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00048380 |
|---|---|
| DOI: | 10.1111/ajd.13895 |
